Your browser doesn't support javascript.
loading
Bayesian Hierarchical Modelling for Histology-Independent Time-to-Event Outcomes in the NICE Single Technology Appraisal of Pembrolizumab for Solid Tumours with MSI-H/dMMR: External Assessment Group Perspective.
Sugden, Bradley M; Grimm, Sabine E; Wolff, Robert; Armstrong, Nigel; Otten, Thomas; Abu-Zahra, Teebah; Perry, Mark; Patel, Mubarak; Chen, Jiongyu; Noake, Caro; Joore, Manuela; Witlox, Willem J A.
Afiliação
  • Sugden BM; Department of Clinical Epidemiology and Medical Technology Assessment, Maastricht University Medical Centre+ (MUMC+), Maastricht, The Netherlands. Bradley.sugden@mumc.nl.
  • Grimm SE; Department of Clinical Epidemiology and Medical Technology Assessment, Maastricht University Medical Centre+ (MUMC+), Maastricht, The Netherlands.
  • Wolff R; Kleijnen Systematic Reviews Limited, York, UK.
  • Armstrong N; Kleijnen Systematic Reviews Limited, York, UK.
  • Otten T; Department of Clinical Epidemiology and Medical Technology Assessment, Maastricht University Medical Centre+ (MUMC+), Maastricht, The Netherlands.
  • Abu-Zahra T; Department of Clinical Epidemiology and Medical Technology Assessment, Maastricht University Medical Centre+ (MUMC+), Maastricht, The Netherlands.
  • Perry M; Kleijnen Systematic Reviews Limited, York, UK.
  • Patel M; Kleijnen Systematic Reviews Limited, York, UK.
  • Chen J; Kleijnen Systematic Reviews Limited, York, UK.
  • Noake C; Kleijnen Systematic Reviews Limited, York, UK.
  • Joore M; Department of Clinical Epidemiology and Medical Technology Assessment, Maastricht University Medical Centre+ (MUMC+), Maastricht, The Netherlands.
  • Witlox WJA; Department of Clinical Epidemiology and Medical Technology Assessment, Maastricht University Medical Centre+ (MUMC+), Maastricht, The Netherlands.
Pharmacoeconomics ; 42(6): 615-618, 2024 Jun.
Article em En | MEDLINE | ID: mdl-38713424
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Avaliação da Tecnologia Biomédica / Teorema de Bayes / Anticorpos Monoclonais Humanizados / Neoplasias Limite: Humans Idioma: En Revista: Pharmacoeconomics Ano de publicação: 2024 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Avaliação da Tecnologia Biomédica / Teorema de Bayes / Anticorpos Monoclonais Humanizados / Neoplasias Limite: Humans Idioma: En Revista: Pharmacoeconomics Ano de publicação: 2024 Tipo de documento: Article